Madrigal Pharmaceuticals, Inc. company logo
Madrigal Pharmaceuticals, Inc. logo

Madrigal Pharmaceuticals, Inc. (MDGL) Earnings Per Share

Annual EPS

-$21.90$1.91-9.54%

Summary

Current Value
As of today, MDGL annual EPS is -$21.90, down -9.54% on
Historical Performance
MDGL annual EPS is down -49.74% over the past 3 years, and down -301.62% over the past 5 years
All-Time High Comparison
MDGL annual EPS is currently -126.97% below its historical high of $81.20 set on
3-Year Low Comparison
MDGL annual EPS is at its 3-year low
Sector Comparison
MDGL annual EPS is higher than 9.45% of companies in Healthcare sector
Analyst Estimate
Analysts estimate MDGL annual EPS at -$10.10, +53.89% higher than the current value
Upcoming Earnings
The next annual earnings release for MDGL is on

EPS Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

MDGL Performance
MetricDateValue1Y3Y5Y15Y
Annual EPS-$21.90-9.5%-49.7%-301.6%-127.0%
Quarterly EPS-$5.08-3.3%-7.0%-35.4%+42.0%
TTM EPS-$13.01+48.1%+18.8%-17.5%+59.6%
Price$505.23+84.3%+68.4%+343.2%+115.5%
Annual Revenue$180.13M+100.0%+100.0%+100.0%+24.9%
PE Ratio-
Annual Net Income-$465.89M-24.7%-92.6%-455.0%-689.1%
Annual Gross Profit$172.80M+10000.0%+10000.0%+10000.0%+100.0%
Shares Outstanding22.71M+3.2%+25.5%+46.5%

EPS Highs

MDGL Annual EPS Highs Comparison
PeriodHighDateCurrent
3Y-$17.23N/A-27.1%
5Y-$13.09N/A-67.3%
All$81.20-127.0%

EPS Lows

MDGL Annual EPS Lows Comparison
PeriodLowDateCurrent
3Y-$21.90at low
5Y-$21.90at low
All-$1,401.05+98.4%

EPS Estimates

MDGL EPS Estimates reported versus estimate values
YearEstimateReportedSurprise / Exp.
-$19.48-$19.99-2.64%
-$23.47-$21.90+6.69%
-$10.10N/A+53.89%
$2.46N/A+111.22%
MDGL EPS Estimates reported versus estimate values chart

🔒 Log In To Unlock Full Data

EPS History

YearValueChange
-$21.90-9.5%
-$19.99-16.0%
-$17.23-17.8%
-$14.63-11.7%
-$13.09-140.1%
-$5.45-145.9%
-$2.22+12.7%
-$2.54+49.9%
-$5.07+99.6%
-$1,401.05-4,501.1%
-$30.45+31.5%
-$44.45-19.8%
YearValueChange
-$37.10-6.0%
-$35.00-7.5%
-$32.55-140.1%
$81.20+184.4%
-$96.25+26.9%
-$131.60-41.4%
-$93.10+13.9%
-$108.15-25.6%
-$86.10-32.3%
-$65.10+57.4%
-$152.95-3,261.5%
-$4.55-

FAQ

  • What is the current annual EPS of MDGL?

    As of today, MDGL annual EPS is -$21.90

  • What is 1-year change in MDGL annual EPS?

    MDGL annual EPS is down -9.54% year-over-year

  • What is 3-year change in MDGL annual EPS?

    MDGL annual EPS is down -49.74% over the past 3 years

  • How far is MDGL annual EPS from its all-time high?

    MDGL annual EPS is currently -126.97% below its historical high of $81.20 set on December 31, 2009

  • How does MDGL annual EPS rank versus sector peers?

    MDGL annual EPS is higher than 9.45% of companies in Healthcare sector

  • How does the analyst estimate for MDGL annual EPS compare to its current value?

    Analysts estimate MDGL annual EPS at -$10.10, +53.89% higher than the current value

  • When is MDGL next annual earnings release?

    The next annual earnings release for MDGL is on

EPS Formula

EPS =  
Net Income - Preferred Dividends
Shares Outstanding

Data Sources & References

  1. MDGL Official Website www.madrigalpharma.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1157601/000162828025048559/0001628280-25-048559-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1157601/000162828025007980/0001628280-25-007980-index.htm
  4. MDGL Profile on Yahoo Finance finance.yahoo.com/quote/MDGL
  5. MDGL Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mdgl